Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Loss of Ten1 in mice causes telomere shortening and symptoms similar to human dyskeratosis congenita.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Atopy and altered T cell functions contribute to Alopecia Areata.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

TGF-alpha is present in sheep and ferret skin and may affect hair growth without directly stimulating cell proliferation.

IL-1β inhibits human hair follicle growth.

TGF-β is found in hair follicles and may cause hair loss in alopecia areata.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Thy-1 protein helps improve blood flow and wound healing in the skin.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

The laser system helps study brain cell functions by precisely removing specific cells and observing changes.

Turning off a specific gene in stem cells speeds up skin healing by helping cells move better.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

A targetoid hair regrowth pattern indicates recovery in alopecia areata.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Thymic stromal lymphopoietin (TSLP) promotes hair growth, especially after skin injury.